Source:http://linkedlifedata.com/resource/pubmed/id/12785015
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-6-4
|
pubmed:abstractText |
Lipopolysaccharides (LPS), or endotoxins, are structural components of gram-negative bacteria implicated in the pathogenesis of septic shock. In this study the antiendotoxin activity of Bac7(1-35), a synthetic peptide based on the sequence of a proline-rich antibacterial peptide from bovine neutrophils, was investigated in vitro and in an experimental rat model of gram-negative septic shock. The ability of Bac7(1-35) to bind LPS from Escherichia coli O111:B4 was determined using a sensitive Limulus chromogenic assay. In the in vivo study, adult male Wistar rats were given an intraperitoneal injection of 1 x 10(9) colony-forming units of E. coli ATCC 25922. All animals were randomized to receive intraperitoneally 1 mg/kg Bac7(1-35), or isotonic sodium chloride solution (control group C1), 60 mg/kg of piperacillin and 1 mg/kg polymyxin B, 1 mg/kg of polymyxin B plus 60 mg/kg of piperacillin, and 1 mg/kg of Bac7(1-35) plus 60 mg/kg of piperacillin. Each group included 15 animals. Bac7(1-35) was found to completely inhibit the LPS procoagulant activity at approximately 10 microM peptide concentration, as determined by in vitro LAL chromogenic assay. Treatment with Bac7(1-35) resulted in significant decrease in plasma endotoxin levels and lethality rates compared with saline injected control animals. No statistically significant differences were noted between Bac7(1-35) and polymyxin B in reducing all variables measured. These results provide evidence for the ability of Bac7(1-35) to effectively bind LPS and protect animals from lethal effects of this molecule, and point to its potential use for the treatment of endotoxin-induced septic shock.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1073-2322
|
pubmed:author |
pubmed-author:CircoRaffaellaR,
pubmed-author:CirioniOscarO,
pubmed-author:D'AmatoGiuseppinaG,
pubmed-author:GhiselliRobertoR,
pubmed-author:GiacomettiAndreaA,
pubmed-author:MocchegianiFedericoF,
pubmed-author:SabaVittorioV,
pubmed-author:ScaliseGiorgioG,
pubmed-author:SkerlavajBarbaraB,
pubmed-author:ZanettiMargheritaM
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
577-81
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12785015-Amino Acid Sequence,
pubmed-meshheading:12785015-Antimicrobial Cationic Peptides,
pubmed-meshheading:12785015-Endotoxins,
pubmed-meshheading:12785015-Escherichia coli,
pubmed-meshheading:12785015-Gram-Negative Bacteria,
pubmed-meshheading:12785015-Kinetics,
pubmed-meshheading:12785015-Lipopolysaccharides,
pubmed-meshheading:12785015-Molecular Sequence Data,
pubmed-meshheading:12785015-Molecular Weight,
pubmed-meshheading:12785015-Peptides
|
pubmed:year |
2003
|
pubmed:articleTitle |
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
|
pubmed:affiliation |
Department of General Surgery, Istituto Nazionale Riposo e Cura Anziani, University of Ancona, Ancona, Italy.
|
pubmed:publicationType |
Journal Article
|